KALA - Kala Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KALA is currently covered by 2 analysts with an average price target of $200.77. This is a potential upside of $199.36 (14139.01%) from yesterday's end of day stock price of $1.41.

Kala Pharmaceuticals's activity chart (see below) currently has 42 price targets and 64 ratings on display. The stock rating distribution of KALA is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 21.85% with an average time for these price targets to be met of 92.56 days.

Highest price target for KALA is $35, Lowest price target is $33, average price target is $34.

Most recent stock forecast was given by YI CHEN from HC WAINWRIGHT on 16-Sep-2025. First documented stock forecast 13-Aug-2017.

Currently out of the existing stock ratings of KALA, 7 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$35

$33.57 (2347.55%)

$12

29 days ago
(16-Sep-2025)

7/15 (46.67%)

$17.53 (100.34%)

242

Buy

$33

$31.57 (2207.69%)

$15

1 months 5 days ago
(10-Sep-2025)

1/4 (25%)

$16 (94.12%)

93

Buy

$15

$13.57 (948.95%)

$15

1 years 1 months 27 days ago
(18-Aug-2024)

2/3 (66.67%)

$8.72 (138.85%)

450

Buy

3 years 2 months 1 days ago
(14-Aug-2022)

0/2 (0%)

$390 (108.33%)

Sell

$75

$73.57 (5144.76%)

3 years 6 months 16 days ago
(29-Mar-2022)

0/2 (0%)

$2 (2.74%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KALA (Kala Pharmaceuticals) average time for price targets to be met?

On average it took 92.56 days on average for the stock forecasts to be realized with a an average price target met ratio 21.85

Which analyst has the current highest performing score on KALA (Kala Pharmaceuticals) with a proven track record?

YI CHEN

Which analyst has the current lower performing score on KALA (Kala Pharmaceuticals) with a proven track record?

DAVID MARIS

Which analyst has the most public recommendations on KALA (Kala Pharmaceuticals)?

Yi Chen works at HC WAINWRIGHT and has 27 price targets and 23 ratings on KALA

Which analyst is the currently most bullish on KALA (Kala Pharmaceuticals)?

David Maris with highest potential upside - $948.57

Which analyst is the currently most reserved on KALA (Kala Pharmaceuticals)?

Chris Schott with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?